Streetbeat News

Earnings

MAR

Marriott International (NASDAQ:MAR) shares dropped 5% despite beating Q2 EPS estimates. The company reported Q2 adjusted EPS of $2.50, surpassing the $2.47 estimate, but missed sales expectations with $6.439 billion versus $6.483 billion. Marriott's FY24 outlook disappointed investors, projecting full-year adjusted EPS between $9.23 and $9.40, below the $9.50 estimate.

Portfolio Pulse from Nabaparna Bhattacharya

July 31, 2024 | 2:21 pm

NCLH

Norwegian Cruise Line's executive announced that the company's increased guidance is entirely due to stronger pricing. This was revealed during a conference call.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 2:18 pm

CLH

Clean Harbors shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY24 adjusted EBITDA guidance.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 2:16 pm

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo for July 31st, 2024, provides a detailed analysis of key price levels for SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA. The memo outlines potential bullish and bearish scenarios for each asset based on proprietary formulas. Additionally, the memo highlights significant economic data releases and the FOMC Interest Rate Decision, which are expected to create a volatile trading environment.

Portfolio Pulse from RIPS

July 31, 2024 | 2:16 pm

CDW

CDW shares are trading lower after the company reported worse-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 2:15 pm

HUM

Humana Inc (NYSE:HUM) reported Q2 earnings that beat expectations but issued a subpar profit outlook, causing its stock to tumble. The company posted adjusted EPS of $6.96, down from $8.94 a year ago, but above the consensus of $5.85. Revenues increased to $29.54 billion, driven by higher Medicare premiums and membership growth. Despite favorable claims development, higher inpatient admissions impacted results. Humana reaffirmed its 2024 adjusted EPS guidance of ~$16.00, below the consensus of $20.31, and expects a 2024 insurance segment benefit ratio of approximately 90%. HUM stock fell 6.32% following the announcement.

Portfolio Pulse from Vandana Singh

July 31, 2024 | 2:01 pm

NCLH

Norwegian Cruise Line Holdings Ltd (NYSE:NCLH) reported strong Q2 fiscal 2024 results with a 7.6% sales growth and a 25.3% increase in operating income. The company raised its 2024 guidance for the third time this year, expecting significant growth in Adjusted EPS and EBITDA. Despite missing sales consensus, NCLH beat EPS expectations and saw high occupancy rates.

Portfolio Pulse from Akanksha Bakshi

July 31, 2024 | 1:58 pm

LFSWF

Lifeist Wellness Inc. reported a 49% YoY drop in Q2 net revenue and plans to move away from its legacy cannabis business. The company is selling its subsidiary CannMart Inc. and shifting focus to Mikra Cellular Sciences to become a leading nutraceutical company.

Portfolio Pulse from Jelena Martinovic

July 31, 2024 | 1:55 pm

MSFT

Microsoft's recent earnings report showed a revenue beat and a 21% YoY increase in cloud revenue, but shares fell due to missed cloud revenue forecasts and lower forward guidance. Despite this, analysts remain optimistic about Microsoft's AI narrative and future growth in Azure revenue.

Portfolio Pulse from Benzinga Neuro

July 31, 2024 | 1:51 pm

AMD

META

NVDA

QCOM

SMH

SPY

The Federal Open Market Committee meets, AMD posts strong Q2 earnings, and NVIDIA along with other chip stocks rise in sympathy with AMD. Meta and Qualcomm are set to report after the market close.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 1:49 pm